---
title: Etiologies-pulmonary hypertension
---
# Etiologies-pulmonary hypertension

## Primary pulmonary arterial HTN (PAH) (group 1)
Precapillary PHT
PCWP ≤15 mmHg
↑ transpulm grad
↑ PVR
* Idiopathic (IPAH): yearly incidence 1–2 per million; mean age of onset 36 y (♂ older than ♀); ♂: ♀ = ~2:1, usually mild ↑ in PAP
* Familial (FPAH)
* Associated conditions (APAH)
* Connective tissue dis.: CREST, SLE, MCTD, RA, PM, Sjögren
* Congenital L→R shunts: ASD, VSD, PDA
* Portopulmonary HTN (? 2° vasoactive substances not filtered in ESLD; ≠ hepatopulmonary syndrome)
* HIV; drugs & toxins: anorexic agents, SSRIs, l-tryptophan
* Pulmonary veno-occlusive disease: ? 2° chemo, BMT; orthopnea, pl eff, CHF, nl PCWP; art vasodil. worsen CHF (AJRCCM 2000;162:1964)
* Pulmonary capillary hemangiomatosis

## Left heart disease (group 2). ↑ PCWP
* Left atrial or ventricular (diastolic or systolic) dysfunction
* Left-sided valvular heart disease (eg, MS/MR)

## Lung diseases and/ or chronic hypoxemia (group 3)
* COPD
* Alveolar hypoventilation (eg, NM disease)
* ILD
* Chronic hypoxemia (eg, high altitude)
* Sleep apnea
* Developmental abnormalities

## Chronic thrombo- embolic dis (group 4)
* Prox or distal PEs; ~½ w/o clinical h/o PE (NEJM 2011;364:351)
* Nonthrombotic emboli (tumor, foreign body, parasites)

## Miscellaneous/ Multifactorial (group 5)
* Sarcoidosis, histiocytosis X, LAM, schistosomiasis, ESRD
* Compression of pulm vessels (adenopathy, tumor, fibrosing mediastinitis, histoplasmosis, XRT)
* Other: thyroid dis., glycogen storage dis., Gaucher dis, HHT, sickle cell, etc., chronic myeloprolif d/o, splenectomy
